Return to study ST000196 main page

Download data matrix(Murine gastrointestinal bile acid profiles before and after antibiotics ESI negative ion mode)

AnalysisSamplesFactorsUnits
ESI negative ion modeS00015978Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015979Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016046Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015980Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015981Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016047Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016048Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015974Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015975Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016043Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016044Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015976Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015977Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016045Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016013Recovery:na | Gender:female | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016014Recovery:na | Gender:female | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016015Recovery:na | Gender:female | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016081Recovery:na | Gender:female | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016082Recovery:na | Gender:female | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016083Recovery:na | Gender:female | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016016Recovery:na | Gender:male | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016017Recovery:na | Gender:male | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016018Recovery:na | Gender:male | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016084Recovery:na | Gender:male | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016085Recovery:na | Gender:male | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00016086Recovery:na | Gender:male | Treatment:No antibioticsug/100mg sample weight
ESI negative ion modeS00015952Recovery:no recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015953Recovery:no recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016019Recovery:no recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016020Recovery:no recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016021Recovery:no recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015986Recovery:no recovery | Gender:female | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00015987Recovery:no recovery | Gender:female | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016052Recovery:no recovery | Gender:female | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016053Recovery:no recovery | Gender:female | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016054Recovery:no recovery | Gender:female | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016010Recovery:no recovery | Gender:female | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016011Recovery:no recovery | Gender:female | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016012Recovery:no recovery | Gender:female | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016078Recovery:no recovery | Gender:female | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016079Recovery:no recovery | Gender:female | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016080Recovery:no recovery | Gender:female | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016006Recovery:no recovery | Gender:female | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016007Recovery:no recovery | Gender:female | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016073Recovery:no recovery | Gender:female | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016074Recovery:no recovery | Gender:female | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016075Recovery:no recovery | Gender:female | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016000Recovery:no recovery | Gender:female | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016001Recovery:no recovery | Gender:female | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016002Recovery:no recovery | Gender:female | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016067Recovery:no recovery | Gender:female | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016068Recovery:no recovery | Gender:female | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016069Recovery:no recovery | Gender:female | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00015954Recovery:no recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015955Recovery:no recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016022Recovery:no recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016023Recovery:no recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016024Recovery:no recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015988Recovery:no recovery | Gender:male | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00015989Recovery:no recovery | Gender:male | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00015990Recovery:no recovery | Gender:male | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016055Recovery:no recovery | Gender:male | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016056Recovery:no recovery | Gender:male | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016057Recovery:no recovery | Gender:male | Treatment:IP clindamycinug/100mg sample weight
ESI negative ion modeS00016008Recovery:no recovery | Gender:male | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016009Recovery:no recovery | Gender:male | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016076Recovery:no recovery | Gender:male | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016077Recovery:no recovery | Gender:male | Treatment:Kanamycin treatedug/100mg sample weight
ESI negative ion modeS00016003Recovery:no recovery | Gender:male | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016004Recovery:no recovery | Gender:male | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016005Recovery:no recovery | Gender:male | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016070Recovery:no recovery | Gender:male | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016071Recovery:no recovery | Gender:male | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00016072Recovery:no recovery | Gender:male | Treatment:Metronidazole treatedug/100mg sample weight
ESI negative ion modeS00015997Recovery:no recovery | Gender:male | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00015998Recovery:no recovery | Gender:male | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00015999Recovery:no recovery | Gender:male | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016064Recovery:no recovery | Gender:male | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016065Recovery:no recovery | Gender:male | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00016066Recovery:no recovery | Gender:male | Treatment:Vancomycin treatedug/100mg sample weight
ESI negative ion modeS00015956Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015957Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015958Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015959Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016025Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016026Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016027Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015960Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015961Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016028Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016029Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016030Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015982Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015983Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016049Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016050Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015991Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00015992Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00015993Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00016058Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00016059Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00016060Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00015984Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015985Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016051Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015994Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00015995Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00015996Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00016061Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00016062Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00016063Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycinug/100mg sample weight
ESI negative ion modeS00015968Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015969Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015970Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016037Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016038Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015971Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015972Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015973Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016039Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016040Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016041Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016042Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015962Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015963Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015964Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016031Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016032Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016033Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015965Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015966Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00015967Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016034Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016035Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
ESI negative ion modeS00016036Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treatedug/100mg sample weight
  logo